Actually, activation of de novo fatty acids synthesis, is exclusive of cancer cells and has an essential role in supporting conversion of nutrients into metabolic components for membrane biosynthesis, energy storage and generation of signaling molecules.61 In fact, several preclinical and clinical studies have been addressed to test the effect of inhibiting fatty acid synthase (FASN) in different cancer types. Here, FASN is linked to cancer.